ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
抗疫概念
876.724
+0.141
0.02%
手動刷新
漲家數:
6
跌家數:
11
平家數:
- -
市盈率:
- -
高:
890.784
開:
876.583
低:
868.008
收:
876.583
成交量:
3.17億
成交額:
22.85億
市值:
5,901.88億
流通市值:
4,898.93億
資料載入中...
總覽
新聞資訊
Lazard Asset Management LLC減持國藥控股(01099)598.56萬股 每股作價17.12港元
智通财经
·
4小時前
君實生物(01877.HK)周一回購30.3萬股 涉430萬元
阿斯达克财经
·
4小時前
勁方醫藥-B(02595.HK)11月16日耗資390.5萬港元回購19.82萬股
中金财经
·
5小時前
君實生物(01877)11月16日斥資約429.99萬港元回購30.3萬股
智通财经
·
5小時前
石藥集團(01093):SYH2051聯合伊立替康脂質體用於治療晚期實體瘤的Ib/II期臨床試驗在中國首個研究中心正式啓動
智通财经
·
5小時前
康希諾生物(06185.HK):Td5cp在中國獲得4至5周歲人群中開展臨床試驗的批准
智通财经
·
5小時前
復星醫藥(02196): FXR0906 注射液用於治療高甘油三酯血癥於中國境內啓動 II 期臨床試驗
智通财经
·
5小時前
白雲山(00874.HK):全資子公司擬參與投資沃博資本大健康有限合夥基金
智通财经
·
6小時前
復星醫藥(600196.SH)控股子公司藥品SRT-003-1獲臨床試驗批准
智通财经
·
6小時前
歌禮制藥-B(01672.HK):歌禮口服與長效注射減重臨床前研究亮相ObesityWeek® 2026
智通财经
·
6小時前
復星醫藥:控股子公司藥品HLX105獲臨床試驗批准
格隆汇
·
6小時前
四環醫藥(00460.HK):軒竹生物(02575.HK)吡洛西利新增適應症納入2026年國家基本醫保藥品目錄
智通财经
·
6小時前
四環醫藥:吡羅西尼片新適應症納入2026年國家醫保目錄,用於HR+/HER2-晚期乳腺癌一線治療
美股速递
·
6小時前
白雲山(600332.SH)子公司擬3.5億港元參投亞洲大健康基金
智通财经
·
7小時前
國藥控股山西明迪康醫藥有限公司60%股權擬轉讓
中国财富网
·
7小時前
同源康醫藥-B(02410)股價下跌8.591%,現價港幣$3.405
阿斯达克财经
·
9小時前
鋰電池板塊走弱 比亞迪電子(00285)跌4.99%、贛鋒鋰業(01772)跌3.22%
金吾财讯
·
9小時前
歌禮制藥-B(01672)股價下跌8.094%,現價港幣$4.315
阿斯达克财经
·
9小時前
勁方醫藥-B(02595)股價顯著下跌11.208%,現價港幣$19.25
阿斯达克财经
·
9小時前
港股異動 | 手機產業鏈延續跌勢 三季度全球手機出貨量急劇惡化 小摩指疲態或延續至明年
智通财经
·
11小時前
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hant/stock/BK1515/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":876.72437,"timestamp":1794816491594,"preClose":876.5833,"halted":0,"volume":316730030,"delay":0,"changeRate":0.000161,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0.141052,"latestTime":"11-16 16:00:00","open":876.5833,"high":890.78424,"low":868.00806,"amount":2284590407,"amplitude":0.025983,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1794879000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1794792600000,1794801600000],[1794805200000,1794816000000]],"pbRate":1.304255,"peRate":17.144287,"turnoverRate":0.004107,"increases":7,"decrements":10,"flats":0,"marketCap":590188199168,"floatMarketCap":489892545280},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":890.78424,"amplitude":0.025983,"preClose":876.5833,"low":868.00806,"pbRate":"1.304255","latestPrice":876.72437,"volume":316730030,"delay":0,"open":876.5833,"prevYearClose":1190.107,"prevWeekClose":876.583,"prevMonthClose":841.933,"prevQuarterClose":925.469,"fiveDayClose":910.034,"twentyDayClose":889.861,"sixtyDayClose":941.274,"secType":"PLATE","market":"HK","turnoverRate":0.004107,"peRate":17.144287,"marketCap":590188199168,"floatMarketCap":489892545280,"timestamp":1794816491594,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":6,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2683151616","title":"Lazard Asset Management LLC減持國藥控股(01099)598.56萬股 每股作價17.12港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683151616","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683151616?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 19:15","pubTimestamp":1794827756,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,11月10日,Lazard Asset Management LLC减持国药控股(01099)598.56万股,每股作价17.12港元,总金额约为1.02亿港元。减持后最新持股数目约为1.87亿股,持股比例为13.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01099","BK1515","BK1197","LU0640798160.USD","EWH","BK1500","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683618028","title":"君實生物(01877.HK)周一回購30.3萬股 涉430萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683618028","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683618028?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 18:33","pubTimestamp":1794825180,"startTime":"0","endTime":"0","summary":"君实生物(01877.HK) 公布,于11月16日回购30.3万股,每股作价介乎14.01至14.34元,涉资约429.99万元。自购回授权决议获通过以来,集团累计回购30.3万股,占已发行股份0.1164%。(da)(港股报价延迟最少十五分钟。沽空资料截至 2026-11-16 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190121165959803_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190121165959803_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1554849/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1554849/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1583","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683187386","title":"勁方醫藥-B(02595.HK)11月16日耗資390.5萬港元回購19.82萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683187386","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683187386?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 18:28","pubTimestamp":1794824895,"startTime":"0","endTime":"0","summary":"格隆汇11月16日丨劲方医药-B(02595.HK)发布公告,2026年11月16日耗资390.5万港元回购19.82万股,回购价格每股19.15-20.48港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261116/32424523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02595","BK1515","09939","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683369004","title":"君實生物(01877)11月16日斥資約429.99萬港元回購30.3萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683369004","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683369004?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 18:14","pubTimestamp":1794824062,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君实生物(01877)发布公告,于2026年11月16日该公司斥资约429.99万港元回购30.3万股,回购价格为每股14.01至14.34港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","BK1583","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683690788","title":"石藥集團(01093):SYH2051聯合伊立替康脂質體用於治療晚期實體瘤的Ib/II期臨床試驗在中國首個研究中心正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2683690788","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683690788?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 18:10","pubTimestamp":1794823806,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)发布公告,集团开发的SYH2051联合伊立替康脂质体用于治疗晚期实体瘤的Ib/II期临床试验已在中国首个研究中心正式启动。该产品是一款高选择性的共济失调-毛细血管扩张症突变基因蛋白激酶抑制剂,注册分类为化学药品1类。该产品选择性抑制细胞脱氧核糖核酸损伤修复系统核心成分ATM激酶活性,可阻止肿瘤细胞DNA损伤修复。本次启动的临床试验为一项多中心、开放设计的Ib/II期临床试验,计划入组晚期实体瘤患者,旨在评估该产品联合伊立替康脂质体的安全性及有效性。目前,该临床试验的参与者招募和筛选工作正在积极推进中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1152091168.USD","LU1807302812.USD","LU0072913022.USD","LU1152091754.HKD","LU0501845795.SGD","KURE","PSYK","BK1521","IE00B031HY20.USD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226287875.USD","LU2039709279.SGD","LU0140636845.USD","LU1813983027.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU0880133367.SGD","BMED","01093","IBBJ","HK0000165453.HKD","LU0314109678.HKD","LU1328277881.USD","IE00BZ08YS42.EUR","LU0067412154.USD","MDTX","IBBQ","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1226288253.USD","LU1951186391.HKD","LU0315179316.USD","SG9999004220.SGD","LU1960683339.HKD","IE00B543WZ88.USD","LU1226287529.USD","BK1515","LU1226287792.SGD","BK1191","IE0008369823.USD","IE0008368742.USD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683069043","title":"康希諾生物(06185.HK):Td5cp在中國獲得4至5周歲人群中開展臨床試驗的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2683069043","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683069043?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 18:05","pubTimestamp":1794823551,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1574","BK1515","BK1161","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683690977","title":"復星醫藥(02196): FXR0906 注射液用於治療高甘油三酯血癥於中國境內啓動 II 期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2683690977","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683690977?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 18:03","pubTimestamp":1794823397,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药(02196)公布,近日,公司控股子公司复星医药产业发展(深圳)有限公司就 FXR0906 注射液用于治疗高甘油三酯血症于中国境内启动 II 期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","MDTX","BK0012","BK0188","PSYK","BK1191","BK0175","BK0028","BK0183","BK1593","BMED","BK0096","IBBJ","BK0239","02196","BK0187","600196","BK1515","IBBQ","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683669268","title":"白雲山(00874.HK):全資子公司擬參與投資沃博資本大健康有限合夥基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2683669268","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683669268?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 17:13","pubTimestamp":1794820424,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1521","BK1515","00874","BK1197","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683870692","title":"復星醫藥(600196.SH)控股子公司藥品SRT-003-1獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2683870692","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683870692?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 17:10","pubTimestamp":1794820205,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药 发布公告,近日,公司控股子公司成都星睿菁烜生物科技有限公司收到国家药品监督管理局关于同意[ 18F]F-SR031 注射液用于实体瘤患者成纤维细胞活化蛋白阳性病灶正电子发射断层扫描显像的临床试验批准。星睿菁烜拟于条件具备后于中国境内开展该药品的 I 期临床研究。以氟[ 18F]标记的FAP抑制剂可与 CAF 表面的 FAP 特异性结合,使 FAP 高表达的肿瘤病灶在PET 显像中呈高摄取,从而用于肿瘤的诊断、分期及疗效评估。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBQ","BMED","BK0239","BK0028","BK0096","BK1593","02196","BK0175","BK1191","BK0187","PSYK","IBBJ","MDTX","BK0196","BK0060","BK0012","600196","BK0188","BK0183","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683694782","title":"歌禮制藥-B(01672.HK):歌禮口服與長效注射減重臨床前研究亮相ObesityWeek® 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2683694782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683694782?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 17:04","pubTimestamp":1794819864,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01672","BK1161","01477","BK1515","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683869178","title":"復星醫藥:控股子公司藥品HLX105獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2683869178","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683869178?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 16:47","pubTimestamp":1794818861,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK1191","BK0012","BK1515","BK0060","02196","BK1593","600196","BK0175","BK0187","BK0096","BK0196","BK0188","BK0028","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683288691","title":"四環醫藥(00460.HK):軒竹生物(02575.HK)吡洛西利新增適應症納入2026年國家基本醫保藥品目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683288691","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683288691?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 16:42","pubTimestamp":1794818543,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1600","BK1191","00460","BK1515","02575","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173914023","title":"四環醫藥:吡羅西尼片新適應症納入2026年國家醫保目錄,用於HR+/HER2-晚期乳腺癌一線治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1173914023","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173914023?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 16:40","pubTimestamp":1794818409,"startTime":"0","endTime":"0","summary":"四环医药宣布,吡罗西尼片的新适应症已被纳入2026年国家医保目录,用于HR+/HER2-晚期乳腺癌的一线治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","00460","BK1600","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683699264","title":"白雲山(600332.SH)子公司擬3.5億港元參投亞洲大健康基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2683699264","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683699264?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 16:21","pubTimestamp":1794817260,"startTime":"0","endTime":"0","summary":"智通财经APP讯,白云山(600332.SH)发布公告,公司全资子公司广药白云山香港有限公司拟出资3.5亿港元认缴沃博资本大健康有限合伙基金(“亚洲大健康基金”)有限合伙份额,占募集完成后基金的比例为35%。该基金重点投向医疗健康行业(包括但不限于医疗保健、生命科学及消费品行业),涵盖早期、成长期及其他投资组合。通过该投资,公司可以更高效地落实国际化战略:一是高效接入海外网络,提升优质项目、前沿技术的信息获取能力;二是基金合作可使公司更灵活开展海外投资布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0097","BK1515","BK0183","BK0012","BK0096","600332","BK0239","BK0175","BK1606","BK1197","BK0188","BK0196","BK0028","00874","BK1191","BK0070","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683699045","title":"國藥控股山西明迪康醫藥有限公司60%股權擬轉讓","url":"https://stock-news.laohu8.com/highlight/detail?id=2683699045","media":"中国财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683699045?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 16:16","pubTimestamp":1794816972,"startTime":"0","endTime":"0","summary":"中国医药集团旗下国药控股山西有限公司近日披露股权转让信息,拟转让国药控股山西明迪康医药有限公司60%股权,转让底价1299.81万元。国药控股山西明迪康医药有限公司成立于2018年8月15日,注册及经营地位于山西省太原市小店区,主营药品、医疗器械批发,配套仓储、冷链配送等医药流通相关业务。核心价值与优势项目核心价值重点体现在资质条件、区位载体、业务延展性等方面。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611163931805243.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611163931805243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","LU1115378108.SGD","09939","BK1500","LU0640798160.USD","01099","BK1515","BK1197","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683484698","title":"同源康醫藥-B(02410)股價下跌8.591%,現價港幣$3.405","url":"https://stock-news.laohu8.com/highlight/detail?id=2683484698","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683484698?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 14:09","pubTimestamp":1794809340,"startTime":"0","endTime":"0","summary":"[下跌股]同源康医药-B(02410) 股价在下午02:09比前收市价下跌8.591%,现股价为港币$3.405。至目前为止,今日最高价为$3.71,而最低价为$3.405。总成交量为38.25万股,总成交金额为港币$134.538万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144019223_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144019223_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2611161796/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2611161796/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1574","02410","BK1161","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683660443","title":"鋰電池板塊走弱 比亞迪電子(00285)跌4.99%、贛鋒鋰業(01772)跌3.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2683660443","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683660443?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 13:52","pubTimestamp":1794808358,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股锂电池板块走弱,截至发稿,中国石墨 跌9.70%,比亚迪电子跌4.99%,赣锋锂业跌3.22%,星源材质跌2.64%,天齐锂业跌2.37%,彩客新能源跌2.08%,正力新能跌1.68%,超威动力跌1.53%。消息面上,东方证券新近研究指,碳酸锂现货价格暂稳,基差偏弱运行。据SMM,中国碳酸锂周度产量环比下降0.43%、周度库存量环比下降1.70%。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1996125","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00951","BK1580","BK1589","002460","LU0348766576.USD","LU0274383008.USD","BK1129","002466","300568","BK1594","BK1509","BK1190","BK1149","SG9999006597.SGD","01986","BK1167","SG9999014674.SGD","02237","BK1116","03677","BK1522","SG9999003461.SGD","09696","BK1515","BK1582","BK1607","BK1110","BK1144","06067","LU0348767384.USD","01772","BK1592","00285","BK1540","LITP","BK1504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683660734","title":"歌禮制藥-B(01672)股價下跌8.094%,現價港幣$4.315","url":"https://stock-news.laohu8.com/highlight/detail?id=2683660734","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683660734?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 13:49","pubTimestamp":1794808140,"startTime":"0","endTime":"0","summary":"[下跌股]歌礼制药-B(01672) 股价在下午01:49比前收市价下跌8.094%,现股价为港币$4.315。至目前为止,今日最高价为$4.63,而最低价为$4.315。总成交量为69万股,总成交金额为港币$305.595万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2611161644/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2611161644/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","01672","01477","BK1191","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683600146","title":"勁方醫藥-B(02595)股價顯著下跌11.208%,現價港幣$19.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2683600146","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683600146?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 13:46","pubTimestamp":1794807960,"startTime":"0","endTime":"0","summary":"[下跌股]劲方医药-B(02595) 股价在下午01:46比前收市价显著下跌11.208%,现股价为港币$19.25。至目前为止,今日最高价为$21.88,而最低价为$19.25。总成交量为210.14万股,总成交金额为港币$4.242千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144017970_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144017970_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2611161632/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2611161632/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02595","159938","09939","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683666470","title":"港股異動 | 手機產業鏈延續跌勢 三季度全球手機出貨量急劇惡化 小摩指疲態或延續至明年","url":"https://stock-news.laohu8.com/highlight/detail?id=2683666470","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683666470?lang=zh_tw&edition=fundamental","pubTime":"2026-11-16 11:37","pubTimestamp":1794800277,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1508","HK0000320264.USD","BK1540","BK1580","BK1149","HK0000306701.USD","BK1515","BK1504","00285","SG9999001069.SGD","LU0348767384.USD","BK1096","BK1582","BK1607","BK1179","06088","01415","BK1167","LU0274383008.USD","HK0000306685.HKD","BK1170","BK1589","LU0348766576.USD","HK0000320223.HKD","01478"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":1,"totalSize":219,"code":"91000000","status":"200"}]}}